Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02299271 · ClinicalTrials.gov registry record · Phase 4
Fascia Iliaca Block for Post-Operative Pain Control After Total Hip Arthroplasty
A Phase 4 study, sponsored by The Christ Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
NCT02299271: Clinical Trial Phase 4 study, sponsored by The Christ Hospital.
NCT02299271 is a Phase 4 study that was terminated before completion, run by The Christ Hospital. The registered enrollment target is 72 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02299271, a Phase 4 study, was terminated before completion, sponsored by The Christ Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
Study Summary
This study evaluates post-operative pain management and narcotic consumption in patients receiving a fascia iliaca block with local anesthetic versus patients receiving fascia iliaca block with saline for total hip arthroplasty.
Primary Outcome
Measured by NRS-11 beginning in post-operative care unit and continuing 24 hours on the post-operative floor.
Interventions
- DRUG Saline
- DRUG Ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-12 |
| Phase | Phase 4 |
Why NCT02299271 stopped before completion
NCT02299271 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT02299271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02299271 about?
NCT02299271 is a clinical study titled "Fascia Iliaca Block for Post-Operative Pain Control After Total Hip Arthroplasty". This study evaluates post-operative pain management and narcotic consumption in patients receiving a fascia iliaca block with local anesthetic versus patients receiving fascia iliaca block with saline for total hip arthroplasty.
What is the current status of trial NCT02299271?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2014-06. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02299271?
The interventions under investigation include: Saline (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT02299271?
This trial is sponsored by The Christ Hospital, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02299271's enrollment target sits among peer trials
72 1035th of 2000 higher than 961 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia